BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 18498745)

  • 1. The CUL7 E3 ubiquitin ligase targets insulin receptor substrate 1 for ubiquitin-dependent degradation.
    Xu X; Sarikas A; Dias-Santagata DC; Dolios G; Lafontant PJ; Tsai SC; Zhu W; Nakajima H; Nakajima HO; Field LJ; Wang R; Pan ZQ
    Mol Cell; 2008 May; 30(4):403-14. PubMed ID: 18498745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a regulatory role of Cullin-RING E3 ubiquitin ligase 7 in insulin signaling.
    Scheufele F; Wolf B; Kruse M; Hartmann T; Lempart J; Mühlich S; Pfeiffer AFH; Field LJ; Charron MJ; Pan ZQ; Engelhardt S; Sarikas A
    Cell Signal; 2014 Feb; 26(2):233-239. PubMed ID: 24219910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cullin7 E3 ubiquitin ligase: a novel player in growth control.
    Sarikas A; Xu X; Field LJ; Pan ZQ
    Cell Cycle; 2008 Oct; 7(20):3154-61. PubMed ID: 18927510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shooting the messenger: CULLIN' insulin signaling with Fbw8.
    Mieulet V; Lamb RF
    Dev Cell; 2008 Jun; 14(6):816-7. PubMed ID: 18539111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CUL7/F-box and WD repeat domain containing 8 (CUL7/Fbxw8) ubiquitin ligase promotes degradation of hematopoietic progenitor kinase 1.
    Wang H; Chen Y; Lin P; Li L; Zhou G; Liu G; Logsdon C; Jin J; Abbruzzese JL; Tan TH; Wang H
    J Biol Chem; 2014 Feb; 289(7):4009-17. PubMed ID: 24362026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mTOR complex 2 regulates proper turnover of insulin receptor substrate-1 via the ubiquitin ligase subunit Fbw8.
    Kim SJ; DeStefano MA; Oh WJ; Wu CC; Vega-Cotto NM; Finlan M; Liu D; Su B; Jacinto E
    Mol Cell; 2012 Dec; 48(6):875-87. PubMed ID: 23142081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Cullin-RING E3 ubiquitin ligase 7 by simian virus 40 large T antigen.
    Hartmann T; Xu X; Kronast M; Muehlich S; Meyer K; Zimmermann W; Hurwitz J; Pan ZQ; Engelhardt S; Sarikas A
    Proc Natl Acad Sci U S A; 2014 Mar; 111(9):3371-6. PubMed ID: 24550499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cullin-RING E3 Ubiquitin Ligase 7 in Growth Control and Cancer.
    Pan ZQ
    Adv Exp Med Biol; 2020; 1217():285-296. PubMed ID: 31898234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the Cullin7 E3 ubiquitin ligase--heterodimerization of cullin substrate receptors as a novel mechanism to regulate cullin E3 ligase activity.
    Ponyeam W; Hagen T
    Cell Signal; 2012 Jan; 24(1):290-5. PubMed ID: 21946088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of insulin receptor substrate-1 by mTORC2 (mammalian target of rapamycin complex 2).
    Destefano MA; Jacinto E
    Biochem Soc Trans; 2013 Aug; 41(4):896-901. PubMed ID: 23863152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CUL7: A DOC domain-containing cullin selectively binds Skp1.Fbx29 to form an SCF-like complex.
    Dias DC; Dolios G; Wang R; Pan ZQ
    Proc Natl Acad Sci U S A; 2002 Dec; 99(26):16601-6. PubMed ID: 12481031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitination and degradation of the hominoid-specific oncoprotein TBC1D3 is mediated by CUL7 E3 ligase.
    Kong C; Samovski D; Srikanth P; Wainszelbaum MJ; Charron AJ; Liu J; Lange JJ; Chen PI; Pan ZQ; Su X; Stahl PD
    PLoS One; 2012; 7(9):e46485. PubMed ID: 23029530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cullin 7 in tumor development: a novel potential anti-cancer target.
    Li Y; Zang A; Fu J; Jia Y
    Neoplasma; 2021 May; 68(3):572-579. PubMed ID: 33618520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of neddylation and deneddylation of cullin1 in SCFSkp2 ubiquitin ligase by F-box protein and substrate.
    Bornstein G; Ganoth D; Hershko A
    Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11515-20. PubMed ID: 16861300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin.
    Takano A; Usui I; Haruta T; Kawahara J; Uno T; Iwata M; Kobayashi M
    Mol Cell Biol; 2001 Aug; 21(15):5050-62. PubMed ID: 11438661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of GATA-binding protein 2 levels via ubiquitin-dependent degradation by Fbw7: involvement of cyclin B-cyclin-dependent kinase 1-mediated phosphorylation of THR176 in GATA-binding protein 2.
    Nakajima T; Kitagawa K; Ohhata T; Sakai S; Uchida C; Shibata K; Minegishi N; Yumimoto K; Nakayama KI; Masumoto K; Katou F; Niida H; Kitagawa M
    J Biol Chem; 2015 Apr; 290(16):10368-81. PubMed ID: 25670854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. beta-arrestin-1 competitively inhibits insulin-induced ubiquitination and degradation of insulin receptor substrate 1.
    Usui I; Imamura T; Huang J; Satoh H; Shenoy SK; Lefkowitz RJ; Hupfeld CJ; Olefsky JM
    Mol Cell Biol; 2004 Oct; 24(20):8929-37. PubMed ID: 15456867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically engineered mouse models for functional studies of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases.
    Zhou W; Wei W; Sun Y
    Cell Res; 2013 May; 23(5):599-619. PubMed ID: 23528706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases.
    Villeneuve NF; Lau A; Zhang DD
    Antioxid Redox Signal; 2010 Dec; 13(11):1699-712. PubMed ID: 20486766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of FBXO31-mediated degradation of DUSP6 dysregulates ERK and PI3K-AKT signaling and promotes prostate tumorigenesis.
    Duan S; Moro L; Qu R; Simoneschi D; Cho H; Jiang S; Zhao H; Chang Q; de Stanchina E; Arbini AA; Pagano M
    Cell Rep; 2021 Oct; 37(3):109870. PubMed ID: 34686346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.